Eagle Pharmaceuticals Inc (EGRX) - Financial and Strategic SWOT Analysis Review

April 2021 | 54 pages | ID: E881C2D6FF7EN
GlobalData

Abstracts

Eagle Pharmaceuticals Inc (EGRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Eagle Pharmaceuticals Inc (Eagle) is a specialty pharmaceutical company which offers proprietary pharmaceutical injectables in the therapy areas of critical care, oncology, and various orphan diseases. The company’s key commercial products encompass pharmaceutical injectables, including Ryanodex for exertional heatstroke; Bendeka, and Belrapzo, both for the treatment of chronic lymphocytic leukemia (CLL), and indolent B-cell non-Hodgkin's lymphoma (NHL). Pipeline products of the company include EP-4104 (dantrolene sodium) for exertional heat stroke (EHS) and nerve agent exposure; EGL-5385-C-1701 (fulvestrant) and Vasopressin injection for blood pressure. The company’s products cater to patients and healthcare professionals in the areas of critical care, orphan diseases, and oncology. Eagle Pharmaceuticals is headquartered in New Jersey, the US.

Eagle Pharmaceuticals Inc Key Recent Developments

Mar 02,2021: Eagle Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results and Provides Pipeline Review
Feb 22,2021: Eagle Pharmaceuticals to Host Fourth Quarter and Full Year 2020 Financial Results and Pipeline Review on March 2, 2021
Nov 02,2020: Eagle Pharmaceuticals strengthens management team to prepare for future growth
Nov 02,2020: Eagle Pharmaceuticals reports third quarter 2020 results
Aug 10,2020: Eagle Pharmaceuticals reports second quarter 2020 results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Eagle Pharmaceuticals Inc - Key Facts
Eagle Pharmaceuticals Inc - Key Employees
Eagle Pharmaceuticals Inc - Key Employee Biographies
Eagle Pharmaceuticals Inc - Major Products and Services
Eagle Pharmaceuticals Inc - History
Eagle Pharmaceuticals Inc - Company Statement
Eagle Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Eagle Pharmaceuticals Inc - Business Description
Product Category: License and Other Revenue
Performance
Product Category: Product Sales
Performance
Product Category: Royalty Revenue
Performance
R&D Overview
Eagle Pharmaceuticals Inc - Corporate Strategy
Eagle Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Eagle Pharmaceuticals Inc - Strengths
Eagle Pharmaceuticals Inc - Weaknesses
Eagle Pharmaceuticals Inc - Opportunities
Eagle Pharmaceuticals Inc - Threats
Eagle Pharmaceuticals Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Eagle Pharmaceuticals Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Mar 02, 2021: Eagle Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results and Provides Pipeline Review
Feb 22, 2021: Eagle Pharmaceuticals to Host Fourth Quarter and Full Year 2020 Financial Results and Pipeline Review on March 2, 2021
Nov 02, 2020: Eagle Pharmaceuticals strengthens management team to prepare for future growth
Nov 02, 2020: Eagle Pharmaceuticals reports third quarter 2020 results
Aug 10, 2020: Eagle Pharmaceuticals reports second quarter 2020 results
Jul 16, 2020: Eagle Pharmaceuticals: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
May 11, 2020: Eagle Pharmaceuticals reports first quarter 2020 results
Mar 02, 2020: Eagle Pharmaceuticals reports fourth quarter and full year 2019 results
Jan 08, 2020: Tyme, Eagle Pharmaceuticals partner for cancer candidate oral

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Eagle Pharmaceuticals Inc, Key Facts
Eagle Pharmaceuticals Inc, Key Employees
Eagle Pharmaceuticals Inc, Key Employee Biographies
Eagle Pharmaceuticals Inc, Major Products and Services
Eagle Pharmaceuticals Inc, History
Eagle Pharmaceuticals Inc, Subsidiaries
Eagle Pharmaceuticals Inc, Key Competitors
Eagle Pharmaceuticals Inc, Ratios based on current share price
Eagle Pharmaceuticals Inc, Annual Ratios
Eagle Pharmaceuticals Inc, Annual Ratios (Cont...1)
Eagle Pharmaceuticals Inc, Annual Ratios (Cont...2)
Eagle Pharmaceuticals Inc, Interim Ratios
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Eagle Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Eagle Pharmaceuticals Inc, Performance Chart (2016 - 2020)
Eagle Pharmaceuticals Inc, Ratio Charts
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021